Nanosonics Limited operates as an infection prevention company globally. The company manufactures and distributes the trophon ultrasound probe disinfector, and its related consumables and accessories; and research, develops, and commercialize of infection control and decontamination products and related technologies. Its product portfolio includes trophon2 that provides protection across various level disinfection HLD cycle; AuditPro nanosonics, an infection control workflow compliance management; Trophon EPR, a patented sonicated mist technology that provides high level disinfection of both endocavitary and surface ultrasound probes; and CORIS, an instrument reprocessing product platform. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
Metrics to compare | NAN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNANPeersSector | |
---|---|---|---|---|
P/E Ratio | 86.5x | −3.6x | −0.5x | |
PEG Ratio | 20.07 | −0.05 | 0.00 | |
Price / Book | 7.6x | 2.8x | 2.6x | |
Price / LTM Sales | 7.8x | 2.6x | 2.9x | |
Upside (Analyst Target) | −3.0% | 188.1% | 51.4% | |
Fair Value Upside | Unlock | 22.3% | 9.5% | Unlock |